With over-20-year experience in API development, Wisdom has established itself as a strategic partner to multiple top-10 global pharmaceutical companies. In recent years, Wisdom has achieved breakthroughs in proprietary technologies such as chiral synthesis and peptide synthesis. It has brought 5 Class-1 innovative drugs to market, obtained approval for over 10 first-to-market generics, and got more than 30 API registration numbers, while cumulatively developing over 500 compounds. The company has adopted a green and sustainable business model characterized by low energy consumption, low emissions, and high efficiency.Our R&D headquarter in Haimenu is equipped with over 200 fume hoods and boasts a robust team of more than 200 scientists, over 30% of whom hold master’s degrees.